Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. Data were extracted from FOS, a Shire-sponsored database,...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Michael, Hughes, Derralynn, Kampmann, Christoph, Larroque, Sylvain, Mehta, Atul, Pintos-Morell, Guillem, Ramaswami, Uma, West, Michael, Wijatyk, Anna, Giugliani, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
SI:Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750577/
https://www.ncbi.nlm.nih.gov/pubmed/26937390
http://dx.doi.org/10.1016/j.ymgmr.2015.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750577/
https://www.ncbi.nlm.nih.gov/pubmed/26937390
http://dx.doi.org/10.1016/j.ymgmr.2015.02.002

Ejemplares similares